Mein Warenkorb

Klotho beta

Klotho beta Molekülinformation

Englischer NameKlotho betaAnzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel3Target-AliasKlotho Beta,Klotho Beta-Like Protein,B-Klotho,Klotho Beta Like,Beta-Klotho,EC 3.2.1,BKL,BetaKlotho,KLB
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical
Englischer NameKlotho beta
Target-AliasKlotho Beta,Klotho Beta-Like Protein,B-Klotho,Klotho Beta Like,Beta-Klotho,EC 3.2.1,BKL,BetaKlotho,KLB
Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel3
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical

Klotho beta Molekülhintergrund

KLB (Klotho Beta) is a Protein Coding gene. Among its related pathways are RET signaling and HIV Life Cycle. GO annotations related to this gene include hydrolase activity, hydrolyzing O-glycosyl compounds and fibroblast growth factor binding. An important paralog of this gene is KL. Klotho Beta is a regulator in multiple metabolic processes, while its role in cancer remains unclear. We found the expression of βKlotho was down-regulated in human hepatocellular carcinoma tissues compared with that in paired adjacent non-tumourous liver tissues. Hepatoma cells also showed decreased expression of βKlotho compared with normal hepatocyte cells. Reintroduction of βKlotho into hepatoma cells inhibited their proliferation.

Klotho beta Molekülalias

betaKlotho,beta-klotho,BKL,KLB,klotho beta like,klotho beta-like protein

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
NGM-313NGM-313; MK-3655Phase 2 ClinicalNGM Biopharmaceuticals IncHepatitis; Metabolic Dysfunction-Associated Steatotic Liver Disease; Obesity
Details
JMT-202JMT202; JMT-202Phase 2 ClinicalShanghai Jmt-Bio IncHypertriglyceridemia
Details
DR-10624DR-10624; DR10624Phase 2 ClinicalZhejiang Doer Biologics CorpDiabetes Mellitus; Diabetes Mellitus, Type 2; Hypertriglyceridemia; Metabolic Dysfunction-Associated Steatotic Liver Disease; Metabolic Syndrome; Obesity; Overweight
Details
  • Molekülinformation
  • Produktliste
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns